Webinars Available
Register: Biotin and Immunoassays: The Good, The Bad, and The Ugly — November 12, 2020
This presentation reviews the clinical utility of biotin and describes why and how biotin is used in the design of immunoassays. Despite having the same potential effect of depressing assay response, elevated serum biotin concentrations can either increase results in competitive assays or decrease results in non-competitive assays.
Learning Objectives:
This basic-level, complimentary webinar is produced by Whitehat Communications. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
About the Speaker:
Learning Objectives:
- Describe what biotin is and why it is used both clinically and in the home health market.
- Explain the role of biotin in immunoassay design and the potential influence of serum biotin on assay results.
- Discuss the pharmacokinetics of biotin and the clinical impact of megadosing on test results.
This basic-level, complimentary webinar is produced by Whitehat Communications. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
About the Speaker:
|
Ellis Jacobs, PhD, DABCC, FAACC
Principal, EJ Clinical Consulting LLC Dr. Ellis Jacobs is an independent consultant and Adjunct Associate Professor of Pathology at The Mount Sinai School of Medicine. He has more than 30 years of career experience in hospital laboratory leadership, clinical laboratory regulatory oversight, and the diagnostic industry, regarding provision of diagnostic services, regulatory compliance, quality systems, product development, and clinical evaluation. Dr. Jacobs obtained a BS degree in Chemistry and Natural Sciences from Muhlenberg College in Allentown, PA, in 1974, and a PhD in Biochemistry from the University of South Carolina in 1979. He completed postdoctoral training in Clinical Chemistry and Toxicology at the University of North Carolina, Chapel Hill, in 1981, and was Director of Stat Labs and POCT at The Mount Sinai Hospital for 19 years. Dr. Jacobs has been involved in establishing clinical, diagnostic, regulatory, and accreditation standards at the local, national, and international levels. He is former Director of the New York State laboratory accreditation program and was appointed Head of the NYS DOH Therapeutic Substance Monitoring and Clinical and Forensic Toxicology Proficiency Testing Programs, and Head of the NYS DOH Limited Service Laboratory Accreditation Program. He is past Chair of the CLSI Expert Panel on POCT and most recently (before becoming a consultant) was Director of Scientific Affairs for Abbott Rapid Diagnostics (formerly Alere). |
Orchard Software is a proud sponsor of this P.A.C.E®-accredited opportunity on behalf of
Whitehat Communications
We thank the Virginia POCC Group for their commitment to supporting continuing education.
|
|
|